A potential new target for treatment of hormone refractory prostate cancer
A new study identifies a protein that modifies the androgen receptor (AR) and influences its ability to regulate target genes linked with the progression of prostate cancer. The research, published by Cell Press in the April 7th issue of the journal Cancer Cell, may also drive creation of new strategies for the treatment of advanced prostate cancer that no longer responds to traditional anti-hormone therapies. The AR is an important mediator for the development and progression of prostate cancer, including the progression to the aggressive and often lethal androgen-independent form of the disease. "Androgen ablation therapy is the most common treatment for advanced prostate cancer," offers senior study author, Dr. Yun Qiu from the University of Maryland School of Medicine. "However, many patients inevitably develop deadly recurrent cancers, which no longer respond to androgen blockade and are resistant to current therapy."
To better understand mechanisms associated with advanced prostate cancer, Dr. Qiu and colleagues performed a screen designed to search for proteins that interact with the AR in hormone-refractory prostate cancer cells. The researchers identified RNF6 as an AR associated protein and demonstrated that RNF6 induced ubiquitination of the AR and promoted AR transcriptional activity. Ubiquitination is a common protein modification that mediates a diverse range of cellular activities. One of the best known functions of ubiquitination is to promote protein degradation. However, ubiquitination of AR by RNF6 appeared to have a stabilizing effect on AR protein.
Importantly, inhibition of RNF6 or interference with ubiquitination of AR altered expression of a specific group of AR target genes and abrogated recruitment of AR and its required coactivators to androgen-responsive regulatory regions in these genes. The researchers went on to show that expression of RNF6 was increased in human prostate cancer tissues that do not respond to androgen ablation and is required for prostate tumor growth under androgen depleted conditions.
Taken together, the findings implicate RNF6 as an important regulator of AR transcriptional activity. "Our work suggests that ubiquitination of AR, and possibly other transcription factors, may function as the scaffold for cofactor recruitment to modulate transcriptional activity and specificity," concludes Dr. Qiu. "Targeting components of the ubiquitination machinery, such as RNF6, may potentially be effective in treatment of advanced prostate cancer."
Source: Cell Press
Articles on the same topic
- Statins alter prostate cancer patients' PSA levelsTue, 28 Apr 2009, 19:50:15 UTC
- Vitamin E, selenium and soy in combination does not prevent prostate cancerSun, 26 Apr 2009, 13:25:21 UTC
- Men treated for localized prostate cancer could benefit from pomegranate juice consumptionSun, 26 Apr 2009, 13:25:18 UTC
- Major statin study reveals several important findings for reducing prostate cancer and diseaseSun, 26 Apr 2009, 5:38:57 UTC
- Statins may exert influence on prostate cancer growth by reducing inflammationSun, 26 Apr 2009, 4:30:29 UTC
- MRI: Effective tool for determining pathologic stage of prostate cancerThu, 23 Apr 2009, 15:58:24 UTC
- Autopsy study links prostate cancer to single rogue cellFri, 17 Apr 2009, 21:08:52 UTC
- New drug shows promise in treating drug-resistant prostate cancerFri, 10 Apr 2009, 14:24:39 UTC
- Gene fusion discovery may lead to improved prostate cancer testThu, 9 Apr 2009, 21:08:17 UTC
- Drug shows activity in men with advanced prostate cancerWed, 8 Apr 2009, 18:51:56 UTC
- New medications show promise in treating drug-resistant prostate cancerTue, 7 Apr 2009, 19:50:19 UTC
Other sources
- Statins Alter Prostate Cancer Patients' PSA Levelsfrom Science DailyWed, 29 Apr 2009, 16:21:05 UTC
- Study bolsters hopes for prostate cancer vaccine rejected by FDAfrom LA Times - ScienceWed, 29 Apr 2009, 7:14:16 UTC
- Statins alter prostate cancer patients' PSA levelsfrom PhysorgTue, 28 Apr 2009, 19:49:04 UTC
- Prostate cancer vaccine extends survival in studyfrom PhysorgTue, 28 Apr 2009, 18:42:10 UTC
- 3-D used to study prostate cancer spreadfrom UPITue, 28 Apr 2009, 16:21:04 UTC
- Avodart, Prostate Drug, Found to Reduce Cancer Riskfrom NY Times HealthTue, 28 Apr 2009, 4:00:11 UTC
- Doctors urge baseline test for prostate cancerfrom PhysorgMon, 27 Apr 2009, 10:21:23 UTC
- Doctors urge baseline test for prostate cancerfrom AP HealthMon, 27 Apr 2009, 4:21:03 UTC
- Statins May Exert Influence On Prostate Cancer Growth By Reducing Inflammationfrom Science DailySun, 26 Apr 2009, 20:57:36 UTC
- Major Statin Study Reveals Several Important Findings For Reducing Prostate Cancer And Diseasefrom Science DailySun, 26 Apr 2009, 20:57:35 UTC
- Suppressor Of Cytokine Signaling (SOCS)-1 Inhibits Prostate Cancer Growthfrom Science DailySun, 26 Apr 2009, 20:57:29 UTC
- Vitamin E, selenium and soy in combination does not prevent prostate cancerfrom PhysorgSun, 26 Apr 2009, 16:56:10 UTC
- Vitamin E, Selenium And Soy In Combination Does Not Prevent Prostate Cancerfrom Science DailySun, 26 Apr 2009, 13:21:57 UTC
- Men Treated For Localized Prostate Cancer Could Benefit From Pomegranate Juice Consumptionfrom Science DailySun, 26 Apr 2009, 13:21:55 UTC
- Statins May Exert Influence On Prostate Cancer Growth By Reducing Inflammationfrom Science DailySun, 26 Apr 2009, 13:21:41 UTC
- Major Statin Study Reveals Several Important Findings For Reducing Prostate Cancer And Diseasefrom Science DailySun, 26 Apr 2009, 13:21:38 UTC
- Suppressor Of Cytokine Signaling (SOCS)-1 Inhibits Prostate Cancer Growthfrom Science DailySun, 26 Apr 2009, 13:21:30 UTC
- Statins may exert influence on prostate cancer growth by reducing inflammationfrom Science BlogSun, 26 Apr 2009, 5:35:24 UTC
- MRI: Effective tool for determining pathologic stage of prostate cancerfrom Science BlogThu, 23 Apr 2009, 16:35:21 UTC
- Potential genetic prostate cancer variation foundfrom PhysorgTue, 21 Apr 2009, 12:28:06 UTC
- Designer immune cells fight prostate cancerfrom News @ NatureMon, 20 Apr 2009, 20:14:31 UTC
- Autopsy study links prostate cancer to single rogue cellfrom Biology News NetSat, 18 Apr 2009, 17:07:17 UTC
- Autopsy Study Links Prostate Cancer To Single Rogue Cellfrom Science DailySat, 18 Apr 2009, 1:35:50 UTC
- Autopsy study links prostate cancer to single rogue cellfrom Science BlogFri, 17 Apr 2009, 21:49:22 UTC
- Autopsy study links prostate cancer to single rogue cellfrom PhysorgFri, 17 Apr 2009, 21:28:10 UTC
- Gene Fusion Discovery May Lead To Improved Prostate Cancer Testfrom Science DailyThu, 16 Apr 2009, 1:35:10 UTC
- Company says prostate cancer vaccine shows promisefrom PhysorgTue, 14 Apr 2009, 15:42:31 UTC
- Company says prostate cancer vaccine shows promisefrom AP HealthTue, 14 Apr 2009, 15:21:26 UTC
- Promising Test for Dendreon’s Prostate Cancer Drugfrom NY Times HealthTue, 14 Apr 2009, 14:56:10 UTC
- Potential New Target For Treatment Of Hormone Refractory Prostate Cancerfrom Science DailyTue, 14 Apr 2009, 2:28:30 UTC
- Drug Shows Activity In Men With Advanced Prostate Cancerfrom Science DailyMon, 13 Apr 2009, 13:21:32 UTC
- New Drug Shows Promise In Treating Drug-resistant Prostate Cancerfrom Science DailySat, 11 Apr 2009, 4:07:20 UTC
- New drug shows promise in treating drug-resistant prostate cancerfrom Science BlogFri, 10 Apr 2009, 14:35:06 UTC
- Gene fusion discovery may lead to improved prostate cancer testfrom Science BlogThu, 9 Apr 2009, 21:42:19 UTC
- Gene fusion discovery may lead to improved prostate cancer testfrom PhysorgThu, 9 Apr 2009, 21:21:13 UTC
- New prostate cancer drugs show promisefrom UPIWed, 8 Apr 2009, 19:14:12 UTC
- A New Tool for Battling Prostate Cancerfrom Science NOWTue, 7 Apr 2009, 22:28:04 UTC
- Prostate drug shows promise in early testingfrom PhysorgTue, 7 Apr 2009, 21:56:20 UTC
- Experimental prostate cancer drug shows promisefrom CBC: HealthTue, 7 Apr 2009, 21:21:15 UTC
- New medications show promise in treating drug-resistant prostate cancerfrom Science BlogTue, 7 Apr 2009, 20:49:23 UTC
- Prostate drug shows promise in early testingfrom AP HealthTue, 7 Apr 2009, 19:28:05 UTC
- Drug trial gives hope of longer life to women fighting ovarian cancerfrom The Guardian - ScienceTue, 7 Apr 2009, 7:42:37 UTC
- A potential new target for treatment of hormone refractory prostate cancerfrom PhysorgMon, 6 Apr 2009, 18:42:09 UTC
- A potential new target for treatment of hormone refractory prostate cancerfrom Science BlogMon, 6 Apr 2009, 16:49:04 UTC
- New Marker For Prostate Cancer Progressionfrom Science DailyThu, 2 Apr 2009, 16:21:24 UTC